Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v2.4.0.8
Document and Entity Information
 9 Months Ended
Sep. 30, 2013
Nov. 14, 2013
Document And Entity Information    
Entity Registrant Name CannaVEST Corp.  
Entity Central Index Key 0001510964  
Document Type 10-Q  
Document Period End Date Sep. 30, 2013  
Amendment Flag true  
Current Fiscal Year End Date --12-31  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   11,744,167
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2013  
EntityWellKnownSeasonedIssuer No  
EntityVoluntaryFilers No  
AmendmentDescription

This Amendment No. 2 to Form 10-Q (“Amendment No. 2”) amends the Quarterly Report of CannaVEST Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2013, as filed with the Securities and Exchange Commission (the “SEC”) on November 14, 2013, as amended by the Amendment No. 1 to the Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, as filed with the SEC on November 21, 2013 (collectively, the “10-Q”). This Amendment No. 2 is being filed for the purpose of restating our Financial Statements, amending related disclosure in the section titled Management’s Discussion and Analysis of Financial Condition and in the Notes to the Financial Statements and conforming the disclosures in the Notes to the Financial Statements to those contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013.

This restatement is related to the reporting of the purchase price and allocation thereof related to the purchase of certain assets of PhytoSPHERE Systems, LLC. We have determined that the purchase price and allocation of the purchase price originally reported did not represent the fair market value of the transaction in accordance with accounting principals generally accepted in the United States. This Amendment No. 2 will include corrections of those amounts and resulting changes to the financial statements.